Immunohistochemical localization and distribution of VIP/PACAP receptors in human lung

Peptides

Volumn 21, Issue 2, 2000, Pages 265-269

  Busto, Rebeca ^a   Prieto, Juan C ^a   Bodega, Guillermo ^a   Zapatero, José ^b   Carrero, Isabel ^c  

^a UNIVERSITY OF ALCALÁ   (Spain)

^b HOSPITAL RAMÓN Y CAJAL   (Spain)

^c UNIVERSITY OF VALLADOLID   (Spain)

Author keywords

Human lung; PAC1 receptor; Pituitary adenylate cyclase activating peptide; Vasoactive intestinal peptide; VPAC1 receptor; VPAC2 receptor

Indexed keywords

HYPOPHYSIS ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE RECEPTOR; RECEPTOR ANTIBODY; RECEPTOR SUBTYPE; VASOACTIVE INTESTINAL POLYPEPTIDE RECEPTOR;

ADULT; ARTICLE; BLOOD VESSEL WALL; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; IMMUNE SYSTEM; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; INFLAMMATION; LEUKOCYTE; LUNG; PRIORITY JOURNAL; RECEPTOR DENSITY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SMOOTH MUSCLE FIBER; TISSUE DISTRIBUTION;

ADULT; ANTIBODIES; BLOTTING, WESTERN; HUMANS; IMMUNOHISTOCHEMISTRY; LUNG; MIDDLE AGED; RECEPTORS, PITUITARY ADENYLATE CYCLASE-ACTIVATING POLYPEPTIDE; RECEPTORS, PITUITARY HORMONE; RECEPTORS, VASOACTIVE INTESTINAL PEPTIDE; RECEPTORS, VASOACTIVE INTESTINAL PEPTIDE, TYPE II;

EID: 0034037320     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0196-9781(99)00202-8     Document Type: Article

References (43)

1. Bellinger D.L., Lorton D., Brouxhon S., Felten S., Felten D.L. The significance of VIP in immunomodulation. Adv Neuroimmunol. 6:1996;5-27.
2. Bockaert J., Pin J.P. Utiliser un recepteur couplé aux protéines G pour communiquer. Un succès évolutif. CR Acad Sci Paris. 321:1998;529-551.
3. Busto R, Carrero I, Guijarro LG, Solano RM, Zapatero J, Noguerales F, Prieto JC. Expression, pharmacology and functional evidence for PACAP/VIP receptors in human lung. Am J Physiol 1999;277:L42-8.
4. Conroy D.M., St Pierre S., Sirois P. Relaxant effects of PACAP on epithelium-intact and -denuded guinea-pig trachea a comparison with VIP . Neuropeptides. 29:1995;121-127.
5. Couvineau A., Rouyer-Fessard C., Darmoul D., Maoret J.J., Carrero I., Ogier-Denis E., Laburthe M. Human intestinal VIP receptor cloning and functional expression of two cDNA encoding proteins with different N-terminal domains . Biochem Biophys Res Commun. 200:1994;769-776.
6. Delgado M., Martínez C., Johnson M.C., Gomáriz R.P., Ganea D. Differential expression of vasoactive intestinal peptide receptors 1 and 2 (VIP-R1 and VIP-R2) mRNA in murine lymphocytes. J Neuroimmunol. 68:1996;27-38.
7. Delgado M., Martínez C., Leceta J., Garrido E., Gomáriz R.P. Differential VIP and VIP1 receptor gene expression in rat thymocyte subsets. Peptides. 17:1996;803-807.
8. Delgado M., Pozo D., Martínez C., Garrido E., Leceta J., Calvo J.R., Gomáriz R.P. Characterization of gene expression of VIP and VIP-1 receptor in rat peritoneal lymphocytes and macrophages. Regul Pept. 62:1996;161-166.
9. Gaytan F., Martínez-Fuentes A.J., García-Navarro F., Vaudry H., Aguilar E. PACAP immunolocalization in lymphoid tissues of the rat. Cell Tissue Res. 276:1994;223-227.
10. Goetzl E.J., Patel D.R., Kishiyama J.L., Smoll A.C., Turck C.W., Law N.M., Rosenzweig S.A., Sreedharan S.P. Specific recognition of the human neuroendocrine receptor for VIP by anti-peptide antibodies. Mol Cell Neurosci. 5:1994;145-152.
11. Harmar A.J., Arimura A., Gozes I., Journot L., Laburthe M., Pisegna J.R., Rawlings S.R., Robberecht P., Said S.I., Sreedharan S., Wank S.A., Waschek J.A. Nomenclature of receptors for VIP and PACAP. Pharmacol Rev. 50:1998;265-270.
12. Hauser-Kronberger C., Hacker G.W., Albegger K., Muss W.H., Sundler F., Arimura A., Dietze O. Distribution of two VIP-related peptides, helospectin and PACAP, in the human upper respiratory system. Regul Pept. 65:1996;203-209.
13. Hoyle C.H.V. Neuropeptide families evolutionary perspectives . Regul Pept. 73:1998;1-33.
14. Ichikawa S., Nakamura K., Uchino S., Sreedharan S.P. Immunohistochemical localization of the VIP1 receptor in human uterine adenocarcinoma. Biomed Res. 17:1996;443-449.
15. Ichikawa S, Sreedharan SP, Owen RL, Goetzl EJ. Immunochemical localization of type I VIP receptor and NK-1-type substance P receptor in rat lung. Am J Physiol. 1995;268:L584-8.
16. Ishihara T., Shigemoto R., Mori K., Takahashi K., Nagata S. Functional expression and tissue distribution of a novel receptor for VIP. Neuron. 8:1992;811-819.
17. Johnson M.C., McCormack R.J., Delgado M., Martínez C., Ganea D. Murine T-lymphocytes express vasoactive intestinal peptide receptor 1 (VIP-R1) mRNA. J Neuroimmunol. 68:1996;109-119.
18. Kaltreider H.B., Ichikawa S., Byrd P.K., Ingram D.A., Kishiyama J.L., Sreedharan S.P., Warnock M.L., Beck J.M., Goetzl E.J. Upregulation of neuropeptides and neuropeptide receptors in a murine model of immune inflammation in lung parenchyma. Am J Respir Cell Mol Biol. 16:1997;133-144.
19. Kimura C., Ohkubo S., Ogi K., Hosoya M., Itoh Y., Onda H., Miyata A., Jiang L., Dahl R.R., Stibbs H.H., Arimura A., Fujino M. A novel peptide which stimulates adenylate cyclase molecular cloning and characterization of the ovine and human cDNAs . Biochem Biophys Res Commun. 166:1990;81-89.
20. Lindén A., Cardell L.O., Yoshihara S., Stjärne P., Nadel J.A. PACAP 1-38 as an inhaled bronchodilator in guinea pigs in vivo. Peptides. 19:1998;93-98.
21. Luts A., Uddman R., Alm P., Basterra J., Sundler F. Peptide-containing nerve fibres in human airways distribution and coexistence pattern . Int Arch Allergy Immunol. 101:1993;52-60.
22. Maruno K., Absood A., Said S.I. VIP inhibits human SCLC proliferation in vitro and in vivo. Proc Natl Acad Sci USA. 95:1998;14373-14378.
23. Maruno K., Said S.I. VIP inhibits the proliferation of SCLC and NSCLC. Ann NY Acad Sci. 805:1996;389-393.
24. Miyata A., Arimura A., Dahl R.R., Minamino N., Uehara A., Jiang L., Culler M., Coy D.H. Isolation of a novel 38 residue-hypothalamic polypeptide which stimulates adenylate cyclase in pituitary cells. Biochem Biophys Res Commun. 164:1989;567-574.
25. Miyata A., Jiang L., Dahl R.R., Kitada C., Kubo K., Fujino M., Minamino N., Arimura A. Isolation of a neuropeptide corresponding to the N-terminal 27 residues of the PACAP with 38 residues (PACAP-38). Biochem Biophys Res Commun. 170:1990;643-648.
26. Ogi K., Miyamoto Y., Masuda Y., Habata Y., Hosoya M., Ohtaki T., Masuo Y., Onda H., Fujino M. Molecular cloning and functional expression of a cDNA encoding a human PACAP receptor. Biochem Biophys Res Commun. 196:1993;1511-1521.
27. Pozo D, Delgado M, Martínez C, Gomáriz RP, Guerrero JM, Calvo JR. Functional characterization and mRNA expression of PACAP type I receptores in rat peritoneal macrophages. Biochim Biophys Acta 1359:1997:250-62.
28. Reubi J.C., Horisberger U., Kappeler A., Laissue J.A. Localization of receptors for VIP, somatostatin, and substance P in distinct compartments of human lymphoid organs. Blood. 92:1998;191-197.
29. Said SI. Vasoactive substances in the lung. In: Proceedings of the Tenth Aspen Emphysema Conference, Aspen, Colorado, June 7-10. US Public Health Service Publication 1967;1787:223-8.
30. Said S.I. VIP in the lung. Ann NY Acad Sci. 527:1988;450-464.
31. Said S.I. Vasoactive intestinal peptide. Raebum D., Giembycz M.A. Airways smooth muscle peptide receptors, ion channels and signal transduction . 1995;87-113 Birkhauser Verlag, Basel, Switzerland.
32. Sakakibara H, Shima K, Said SI. Characterization of VIP receptors on rat alveolar macrophages. Am J Physiol 1994;267:L256-62.
33. Schachter M., Dickinson K.E.J., Miles C.M., Sever P.S. Characterization of high-affinity VIP receptor in human parenchyma. FEBS Lett. 199:1986;125-129.
34. Segura J.J., Guerrero J.M., Goberna G., Calvo J.R. Characterization of functional receptors for VIP in rat peritoneal macrophages. Regul Pept. 33:1991;133-143.
35. Shioda S., Shuto Y., Somogyvári-Vigh A., Legradi G., Onda H., Coy D.H., Nakajo S., Arimura A. Localization and gene expression of the receptor for PACAP in the rat brain. Neurosci Res. 28:1997;345-354.
36. Shivers B.D., Görcs T.J., Gottschall P.E., Arimura A. Two high affinity binding sites for PACAP have different tissue distributions. Endocrinology. 128:1991;3055-3065.
37. Sreedharan S.P., Patel D.R., Huang J.X., Goetzl E.J. Cloning and functional expression of a human neuroendocrine VIP receptor. Biochem Biophys Res Commun. 193:1993;546-553.
38. Sundler F., Ekblad E., Grunditz T., Håkanson R., Uddman R. VIP in the peripheral nervous system. Ann NY Acad Sci. 527:1988;143-167.
39. Svoboda M., Tastenay M., Van Rampelbergh J., Grossens J.F., De Neef P., Waelbroeck M., Robberecht P. Molecular cloning and functional characterization of a human VIP receptor from SUP-T1 lymphoblasts. Biochem Biophys Res Commun. 205:1994;1617-1624.
40. Uddman R., Luts A., Arimura A., Sundler F. PACAP, a new VIP-like peptide in the respiratory tract. Cell Tissue Res. 265:1991;197-201.
41. Usdin T.B., Bonner T.I., Mezey E. Two receptors for VIP with similar specificity and complementary distributions. Endocrinology. 135:1994;2662-2680.
42. Wagner U., Bredenbröker D., Storm B., Tackenberg B., Fehmann H.C., Von Wichert P. Effects of VIP and related peptides on airway mucus secretion from isolated rat trachea. Peptides. 19:1998;241-245.
43. Zia F., Fagarasan M., Bitar K., Coy D.H., Pisegna J.R., Wank S.A., Moody T.W. PACAP receptors regulate the growth of NSCLC. Cancer Res. 55:1995;4886-4891.